MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Fatigue in Parkinson’s Disease: Prevalence and Risk Factors

C. Falup-Pecurariu, I. Murasan, D. Rusu, B. Opritoiu, L. Ungureanu, L. Irincu, I. Despa, S. Diaconu (Brasov, Romania)

Meeting: 2024 International Congress

Abstract Number: 320

Keywords: Excessive daytime sleepiness(EDS), Parkinson’s, Sleep disorders. See also Restless legs syndrome: Clinical features

Category: Parkinson's Disease: Non-Motor Symptoms

Objective: To determine the prevalence of fatigue among people with PD (PwP) in comparison to the general population and to identify fatigue associated factors.

Background: Fatigue is one of the most frequently encountered non-motor symptoms in Parkinsons disease (PD), its consequences having a great impact on all aspects of daily life.

Method: In this case-control study, 131 PD patients and 131 healthy controls were enrolled. For the assessment of fatigue in PwP the following scales were used: FIS, Chalder and Parkinson Fatigue Scale (PFS-16).

Results: Fatigue was found to be more frequent in PD patients compared to healthy controls. By comparing total mean scores of the Chalder scale, it was revealed that PD patients scored higher for each of the composing items, the difference in items 1-9 being statistically significant (p < 0,05). In FIS, PFS-16 and Chalder scales, progressively higher scores were registered in patients in advanced H&Y stages compared to those with early PD (p < 0,001 for FIS and PFS-16, p = 0,10 for Chalder). Patients with fatigue have less estimated hours of sleep per night compared to those without fatigue (6,04 ± 1,76 hours vs. 6,90 ± 1,41, p = 0,002). Disease duration, motor status, presence of sleep disorders, insomnia, pain and EDS were all associated with fatigue when independentely evaluated (p < 0,001).

Conclusion: The prevalence of fatigue is higher in PwP, increasing as the disease progresses. Fatigue is also associated with a wide range of other non-motor symptoms.

To cite this abstract in AMA style:

C. Falup-Pecurariu, I. Murasan, D. Rusu, B. Opritoiu, L. Ungureanu, L. Irincu, I. Despa, S. Diaconu. Fatigue in Parkinson’s Disease: Prevalence and Risk Factors [abstract]. Mov Disord. 2024; 39 (suppl 1). https://www.mdsabstracts.org/abstract/fatigue-in-parkinsons-disease-prevalence-and-risk-factors/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2024 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/fatigue-in-parkinsons-disease-prevalence-and-risk-factors/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley